Live tape
Top 8, mentions 7d14,338NVDA4,854 mentions▲ +0.04GOOGL2,061 mentions▲ +0.04SPY1,736 mentions▲ +0.06QQQ1,554 mentions▲ +0.05AMD1,212 mentions▲ +0.08SPCX1,106 mentions▲ +0.05TSLA954 mentions▲ +0.04SNDK861 mentions▲ +0.05

Equity · Healthcare

SPRY

NASDAQ

ARS Pharmaceuticals (SPRY)

3.15 USD +13.51% vs prior close Nov 9, 2026
ARS Pharmaceuticals, Inc. price graph
55 sessions
8 2 12 Aug 9 Nov

The line runs 6 USD on 12 August through 3.15 USD on 9 November, on a scale from 2 to 8. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Market cap
316.7M USD
Revenue, year to Dec 2025
84.3M USD
EPS, diluted, year to Dec 2025
−1.74 USD
Avg volume
143.5K
Mentions, 30 days
1

as of Nov 9, 2026

Have ARS Pharmaceuticals (SPRY) insiders bought or sold shares recently?

SPRY's newest Form 4 filing is dated 12 June 2026: none in the last 90 days.

Form 4

Have ARS Pharmaceuticals (SPRY) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
12 Jun 2026Fitzpatrick Alexander AChief Legal OfficerSell3,35534K USD
12 Jun 2026Karas EricChief Commercial OfficerSell25,000250K USD
13 Nov 2025Dorsey BrianChief Operating OfficerSell21,828190K USD
12 Nov 2025Chakma JustinChief Business OfficerSell166,3801.5M USD
Sold4 open-market sales216,563$1.95M
4 other filings: grants, exercises, tax withholding and transfers, not trades
Have ARS Pharmaceuticals (SPRY) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
12 Jun 2026Karas EricChief Commercial OfficerOption exercise25,00038K USD
13 Nov 2025Dorsey BrianChief Operating OfficerOption exercise21,82814K USD
12 Nov 2025Shah PratikGift350,000
12 Nov 2025Chakma JustinChief Business OfficerOption exercise30,00025K USD

Which funds hold ARS Pharmaceuticals (SPRY)?

8 of the 45 institutional funds we track reported a ARS Pharmaceuticals position for the quarter ended 30 Jun 2026 — a combined 34.1M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold ARS Pharmaceuticals (SPRY)?
FundPositionSharesValueShares q/q
Millennium ManagementTrimmed2,400,93719.2M USD−59.9%
Third PointHeld (±25%)1,000,0008.0M USD
Citadel AdvisorsTrimmed531,0634.3M USD−70.1%
Marshall WaceHeld (±25%)123,714991K USD+17.8%
Balyasny Asset ManagementHeld (±25%)64,658518K USD+4.7%
Two Sigma InvestmentsNew position52,400420K USD
Tudor Investment CorpNew position45,895368K USD
AQR Capital ManagementAdded35,676286K USD+37.9%
D. E. Shaw & Co.Exited

What has been filed or recorded for ARS Pharmaceuticals (SPRY)?

The filings we hold for ARS Pharmaceuticals, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for ARS Pharmaceuticals (SPRY)?
And
13 Oct 2026Fails to deliverShares failed to deliver2,132 shares9K USD notional · 0.002% of shares out
05 Oct 2026Fails to deliverShares failed to deliver8 shares33 USD notional · <0.001% of shares out
30 Sep 2026Fails to deliverShares failed to deliver21,210 shares93K USD notional · 0.021% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.36 USDRevenue $38M
30 Sep 2026FinancialsTotal assets251.5M USDat period end
30 Sep 2026FinancialsTotal equity−12.0M USDat period end
29 Sep 2026Fails to deliverShares failed to deliver1,628 shares7K USD notional · 0.002% of shares out
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.63 USDRevenue $34M
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.61 USDRevenue $23M
31 Dec 2025Annual reportFY 2025 reportedEPS −1.74 USDRevenue $84M
31 Dec 2025FinancialsRevenue84.3M USDfiscal year
31 Dec 2025FinancialsNet income−171.3M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−1.74 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.52 USDRevenue $33M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.46 USDRevenue $16M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.35 USDRevenue $8M
31 Dec 2024Annual reportFY 2024 reportedEPS 0.08 USDRevenue $89M

What is Reddit saying about ARS Pharmaceuticals (SPRY)?

Reddit mentioned SPRY 1 times in the 30 days to 10 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 10 November 2026.

30-day window, Method

1mentions, 30 days
1communities

How do Reddit mentions of ARS Pharmaceuticals (SPRY) compare with its price?

Share ↗
Post on X Share on Reddit Share on LinkedIn
1 mentions

Which subreddits are talking about ARS Pharmaceuticals (SPRY)?

30 days

Which subreddits are talking about ARS Pharmaceuticals (SPRY)?
CommunityShareMentionsNet sentiment
r/stocks100%1+0.16

What do people ask about ARS Pharmaceuticals (SPRY)?

From live data
What did ARS Pharmaceuticals shares close at?3.15

ARS Pharmaceuticals closed at 3.15 USD on 9 Nov 2026, up 13.51% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is ARS Pharmaceuticals’ market cap?316.7M

ARS Pharmaceuticals is worth 316.7M USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.

What is ARS Pharmaceuticals’ revenue?84.3M

ARS Pharmaceuticals reported revenue of 84.3M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have ARS Pharmaceuticals insiders bought or sold shares recently?

No ARS Pharmaceuticals insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 12 Jun 2026 (SEC Form 4). See Insiders

Which funds own ARS Pharmaceuticals?8 of 45

8 of the 45 funds we track reported a ARS Pharmaceuticals position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Third Point and Citadel Advisors. See Funds

When did ARS Pharmaceuticals last report earnings?−0.36

ARS Pharmaceuticals last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.36 USD; no next date is announced in SEC filings yet. See Filings

What is Reddit saying about ARS Pharmaceuticals?1 mentions

ARS Pharmaceuticals was mentioned 1 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  8. SEC EDGARreported earnings figures and scheduled report dates
  9. SEC EDGARValuation computed from SEC EDGAR filings